.Home   Medical   Education   Tourism   Gem 'n' Jewellery    Wedding   Directory       


 
          Drug Update...
 

Neurology / Psychiatry


Zaleplon, a novel hypnotic agent was approved last year for the treatment of insomnia. Dexmedetomidine hydrochloride, a relatively selective a2-adrenoreceptor agonist with sedative properties was also introduced last year for the sedation of mechanically ventilated intensive care patients.

Levetiracetam, was approved last year as an adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. Its exact mechanism of action is as yet unclear.

BACK

|About Us| |Guest Book| |Contact Us|

©Readiprintworld.com, 2000